Uniqure Nv

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$49.04

+4.65 (+10.48%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 16 76%

Hold 5 24%

Sell 0 0%

Price Target

Analyst Price Target -64.3% upside

Low Target $11.65

Average Target $17.51

High Target $27.07

Current Price $49.04

Current
$49.04

Target
$17.51

$11.65 $17.51 avg $27.07

Scenario Analysis

Bear Case

$11.65

-76.2%

Low target

Base Case

$17.51

-64.3%

Avg target

Bull Case

$27.07

+-44.8%

High target

Risk/Reward

0.6x

Unfavorable

Price in Context

52-Week High

$71.50

-31.4% from high

52-Week Low

$8.73

+461.7% from low

Target vs 52W High

$17.51

-75.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%